Psychedelics company engaging in development, cultivation, extraction, processing and distribution of functional mushrooms Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) announced that it will be officially launching its recently completed psilocybin cultivation facility with a grand opening event and reception for investors, stakeholders and members of the media.
The grand opening event of the facility is slated for May 27th, 2022. The company’s executive team and advisory board will be welcoming guests and dignitaries from the psychedelic industry, medical and public health field, local and national politics to celebrate the significant milestone.
At the event, renowned author and journalist in the psychedelics industry, Amanda Siebert, will act as the Master of Ceremonies.
“Psychedelics continue to capture the imagination of people looking for hope and better quality of life, specifically those suffering with debilitating mental health conditions. By having the largest GMP-grade Health Canada licensed mushroom cultivation facility in Canada, we have positioned Optimi to be the number one supplier of safe, natural psilocybin, and we feel good about setting the safest and most stringent production standards in the industry,” said the CEO of Optimi Health, Bill Ciprick.
The company was granted a Dealer’s License by Health Canada back in February and since then, the company’s business development team has been focusing on securing supply deals and letters of intent with pharmaceutical companies, other suppliers and other drug developers interested in their natural GMP-grade product.